SCHEMBL5801995

SCHEMBL5801995

c1cn(-c2nc(NCc3ccc4c(c3)OCCO4)c3c4c(sc3n2)CCCC4)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 8/20 0.46
NOS1 P29475 2/20 0.46
HTT P42858 5/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
PTPN12 Q05209 1/20 0.42
PTPN22 Q9Y2R2 1/20 0.42
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 5/20 0.42
HSD17B10 Q99714 3/20 0.42
ALOX15 P16050 3/20 0.41
USP2 O75604 2/20 0.41
LMNA P02545 1/20 0.41
PDE5A O76074 1/20 0.40
MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5798039 0.95 PTPN12 (0.47) NOS2NOS1HTTMAPTSMN1; SMN2
SCHEMBL7129570 0.86 HTT (0.48) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5798539 0.86 NOS2 (0.49) NOS2NOS1HTTMAPTSMN1; SMN2
SCHEMBL8205107 0.85 HTT (0.44) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5782312 0.85 HTT (0.45) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL7130864 0.85 HTT (0.45) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5801996 0.85 HTT (0.48) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5798508 0.84 PDE5A (0.57) HTTMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5117633 0.84 ALDH1A1 (0.50) NOS2NOS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL5781706 0.84 HTT (0.48) HTTMAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685136-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005047292-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2005-05-26 WO disclosed
EP-0920431-B1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2003-02-26 EP disclosed
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed
US-6110920-A TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-29 US disclosed